Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitapex is a premixed endodontic filling material composed of calcium hydroxide, iodoform, and silicone oil. It is primarily used in pediatric dentistry for the root canal treatment (pulpectomy) of primary (deciduous) teeth and for apexification in permanent teeth. The calcium hydroxide component (approximately 30%) provides a high pH environment (around 12) that is bactericidal and promotes the formation of a mineralized tissue barrier. Iodoform (approximately 40%) serves as a radiopaque agent and provides sustained antimicrobial properties. The silicone oil vehicle (approximately 22%) ensures the paste remains stable and flowable for easy delivery into the root canal. Vitapex is designed to be resorbable, matching the physiological resorption of primary tooth roots, which prevents interference with the eruption of permanent successors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vitapex.